Cargando…
A Novel Prodrug Approach for Central Nervous System-Selective Estrogen Therapy
Beneficial effects of estrogens in the central nervous system (CNS) results from the synergistic combination of their well-orchestrated genomic and non-genomic actions, making them potential broad-spectrum neurotherapeutic agents. However, owing to unwanted peripheral hormonal burdens by any current...
Autores principales: | Prokai-Tatrai, Katalin, Prokai, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891678/ https://www.ncbi.nlm.nih.gov/pubmed/31752337 http://dx.doi.org/10.3390/molecules24224197 |
Ejemplares similares
-
Prodrugs of Thyrotropin-Releasing Hormone and Related Peptides as Central Nervous System Agents
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2009) -
Design and Exploratory Neuropharmacological Evaluation of Novel Thyrotropin-Releasing Hormone Analogs and Their Brain-Targeting Bioprecursor Prodrugs
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2013) -
Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2019) -
Brain-Selective Estrogen Therapy Prevents Androgen Deprivation-Associated Hot Flushes in a Rat Model
por: Merchenthaler, Istvan, et al.
Publicado: (2020) -
The Utility of Oligopeptidase in Brain-Targeting Delivery of an Enkephalin Analogue by Prodrug Design
por: Prokai-Tatrai, K, et al.
Publicado: (2008)